While body weight and metabolic phenotypes remain the primary endpoints, the outcome spectrum is progressively extending toward lipotoxic load [e.g., hepatic fat and visceral adipose tissue (VAT)], inflammatory/cardiometabolic risk markers, and reproductive outcomes with higher clinical decision-making value, such as menstruation, ovulation, and pregnancy
But uncontrolled use risks severe allergic reactions and liver damage
Platelet-rich plasma injections take a small sample of your own blood, concentrate the platelets to 5 to 7 times their normal level, and inject that concentration under ultrasound guidance directly into the damaged tissue
Saskatchewan: Learn more about Saskatchewan Health Coverage here
Rather than a verdict, this editorial lays out the markers a careful reader should check for any GLP-1 telehealth service and how Ros described model maps to them